Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley C Jordan

Showing results (91-100 of 191) with videos related to

Pageof 20
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 18, 2020
Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumabStanley C Jordan, Klaus Kucher, Morten Bagger, et al.
Pediatric Transplantation|August 14, 2021
Development of CMV-specific cytotoxic T cells (CMV-Tc) in pediatric renal transplant recipients with CMV viremiaHelen Pizzo, Bongha Shin, Jon Garrison, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2019
Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation SystemSupreet Sethi, Reiad Najjar, Alice Peng, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2016
Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximabJoseph Kahwaji, Stanley C Jordan, Reiad Najjar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 7, 2019
Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipientsEdmund Huang, Supreet Sethi, Alice Peng, et al.
Transplantation|October 1, 2019
Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant RecipientsSupreet Sethi, Reiad Najjar, Alice Peng, et al.
Transplant Immunology|May 18, 2010
Cellular allo reactivity against paternal HLA antigens in normal multiparous females as detected by intracellular cytokine flow cytometry remains elevated over years despite diminution of anti-HLA antibody levelsMieko Toyoda, Shili Ge, Andy Pao, et al.
Clinical Case Reports|March 2, 2023
Linear IgA bullous dermatosis and elevated bullous interleukin-6 levels: Responsive to treatment with Anti-IL-6 receptor monoclonalsStanley C Jordan, Bonnie Balzer, Cynthia Nast, et al.
Transplantation Direct|October 8, 2025
Tocilizumab Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney TransplantationEdmund Huang, Michie Adjei, Alice Peng, et al.
Transplantation|August 1, 2022
An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft FunctionEdmund Huang, Mark Haas, Matt Gillespie, et al.
Pageof 20

Showing results (91-100 of 191) with videos related to

Sort By:
Pageof 20
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 18, 2020
Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumabStanley C Jordan, Klaus Kucher, Morten Bagger, et al.
Pediatric Transplantation|August 14, 2021
Development of CMV-specific cytotoxic T cells (CMV-Tc) in pediatric renal transplant recipients with CMV viremiaHelen Pizzo, Bongha Shin, Jon Garrison, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2019
Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation SystemSupreet Sethi, Reiad Najjar, Alice Peng, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2016
Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximabJoseph Kahwaji, Stanley C Jordan, Reiad Najjar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 7, 2019
Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipientsEdmund Huang, Supreet Sethi, Alice Peng, et al.
Transplantation|October 1, 2019
Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant RecipientsSupreet Sethi, Reiad Najjar, Alice Peng, et al.
Transplant Immunology|May 18, 2010
Cellular allo reactivity against paternal HLA antigens in normal multiparous females as detected by intracellular cytokine flow cytometry remains elevated over years despite diminution of anti-HLA antibody levelsMieko Toyoda, Shili Ge, Andy Pao, et al.
Clinical Case Reports|March 2, 2023
Linear IgA bullous dermatosis and elevated bullous interleukin-6 levels: Responsive to treatment with Anti-IL-6 receptor monoclonalsStanley C Jordan, Bonnie Balzer, Cynthia Nast, et al.
Transplantation Direct|October 8, 2025
Tocilizumab Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney TransplantationEdmund Huang, Michie Adjei, Alice Peng, et al.
Transplantation|August 1, 2022
An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft FunctionEdmund Huang, Mark Haas, Matt Gillespie, et al.
Pageof 20